Biogen Inc., 10% Owner at SANGAMO THERAPEUTICS, INC (SGMO), sold 2,764 shares at $8.51 ($24K) on 2021-12-28, disclosed to the SEC on 2021-12-30.
Open-market sale of $24k SGMO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| SGMO | SELL | 2021-12-28 | $1.4M | — | Filing → |
| SGMO | SELL | 2021-12-10 | $405K | — | Filing → |
| SGMO | SELL | 2021-12-09 | $2.2M | — | Filing → |